Rheum

Systemic sclerosis: ACR 8 questions, need 10 points 

All nonbiologic disease-modifying antirheumatic drugs should be continued throughout the perioperative period in patients with rheumatologic disease undergoing elective arthroplasty.

Biologic agents should be withheld for one dosing cycle preoperatively, before arthroplasty, with surgery performed at the end of the cycle and resumed when the wound shows evidence of healing